Harmony Biosciences (HRMY) Announce Sandip Kapadia as CFO

Go back to Harmony Biosciences (HRMY) Announce Sandip Kapadia as CFO

Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer

March 15, 2021 8:05 AM EDT

PLYMOUTH MEETING, Pa., March 15, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the appointment of Sandip Kapadia as Chief Financial Officer effective March 29, 2021. Mr. Kapadia is an accomplished executive with more than two decades of operational experience in leading finance operations, supporting commercialization, raising capital and providing strategic guidance within the healthcare sector. 

... More